Condition

Recurrent Ovarian Cancer clinical trials and research

• 9Clinical trials
• 12Countries

Newest Recurrent Ovarian Cancer clinical trials

All recruiting trials (9)

• SYS6041 in combination therapy for recurrent ovarian cancer

  This study tests SYS6041 combined with other cancer drugs in adults whose ovarian cancer has come back to see if it’s safe and possibly effective.

  Recruiting Phase 2 CSPC Megalith Biopharmaceutical Co.,Ltd. · Shanghai, Shanghai Municipality · NCT07714668

• Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer (REGYNERA-tion) Registry

  This registry tests how reirradiation and total ablative strategies are used in real-world care for adults with recurrent gynecologic cancers and tracks outcomes to see what happens after these treatments.

  Recruiting Affidea Nu-med Center of Oncological DIagnostics and Therapy · Zamość, Lublin Voivodeship · NCT07667192

• Autologous TILs for Recurrent Ovarian Cancer

  A patient-focused study tests whether a patient’s own tumor-infiltrating lymphocytes can be safely given as a one-time infusion to see if it helps with recurrent ovarian cancer.

  Recruiting CHA University · Gyeonggi-do, Bundang-gu · NCT07651124

• CapsuleX combined with cisplatin for platinum-resistant recurrent ovarian cancer

  This study will try adding CapsuleX to cisplatin to see if it helps people with platinum-resistant recurrent ovarian cancer have better tumor responses.

  Recruiting The First Hospital of Jilin University · Changchun, Jilin · NCT07495384

• HS-10502 combination treatment for advanced solid tumors

  This study will test whether the oral drug HS-10502, given with other cancer medicines, is safe and can help people with advanced solid tumors such as recurrent ovarian cancer, HER2‑negative or triple‑negative breast cancer, and advanced prostate cancer.

  Recruiting Phase 1 Jiangsu Hansoh Pharmaceutical Co., Ltd. · Shanghai, Shanghai Municipality · NCT06769425

• Combination therapy for recurrent ovarian cancer

  This study is testing a new combination of treatments for women with recurrent ovarian cancer to see if it can help them feel better and improve their outcomes.

  Recruiting Phase 2 Akeso · Shanghai · NCT06560112

• CPI-0209 combined with Carboplatin for recurrent ovarian cancer

  This study is testing if a new treatment called CPI-0209, when combined with Carboplatin, can help women with recurrent ovarian cancer feel better and stay cancer-free longer.

  Recruiting Phase 1 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT05942300

• Combination therapy for recurrent ovarian cancer using doxorubicin and Ashwagandha

  This study is testing if a combination of a cancer drug and Ashwagandha can help women with recurrent ovarian cancer feel better and respond to treatment.

  Recruiting Phase 1/2 University of Louisville · Louisville, Kentucky · NCT05610735

• Treatment for recurrent ovarian and other MUC16+ cancers using REGN4018 and cemiplimab

  This study is testing if a new treatment combining REGN4018 and cemiplimab can help adults with recurrent ovarian and other MUC16+ cancers feel better when other options have run out.

  Recruiting at 49 sites Phase 1/2 Regeneron Pharmaceuticals · Birmingham, Alabama and 53 other locations · NCT03564340

Related topics

Quick answers

How many Recurrent Ovarian Cancer clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 12 countries. The most sites are in China (4 trials), United States (3 trials), South Korea (2 trials), Australia (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 1: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →